Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingwei Wei

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Cancer|November 8, 2024
Immunofluorescence-Verified Sphingolipid Signatures Indicate Improved Prognosis in Liver Cancer PatientsLujuan Pan, Huijuan Huang, Pengpeng Zhang, et al.
Vaccines|April 27, 2026
Safety and Immunogenicity of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase III, Randomized, Blinded, Positive-Control Clinical Trial in Infants Aged Two MonthsHao Zhang, Yanjun Chen, Bidan Xu, et al.
BMJ Open|October 5, 2023
Single-arm, phase II study of intra-arterial chemotherapy plus total neoadjuvant therapy to optimise complete response in distal rectal cancer: a study protocolWenpeng Huang, Puda Huang, Houji Guo, et al.
Infectious Diseases and Therapy|July 6, 2026
Safety Profiles of Seasonal Influenza Vaccines in Chinese Children and Adolescents: A Pooled Analysis of Five Clinical StudiesLe Hu, Yue Liu, Siyue Jia, et al.
Frontiers in Immunology|September 5, 2024
A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in ChinaXu Han, Hongxing Pan, Pengfei Jin, et al.
Human Vaccines & Immunotherapeutics|February 24, 2025
Immunogenicity and safety of 1 versus 2 doses of quadrivalent-inactivated influenza vaccine in children aged 3-8 years with or without previous influenza vaccination historiesFeng Wen, Sheng Liu, Li Zhou, et al.
Vaccines|June 27, 2024
Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6-17 Years: An Immunobridging TrialXu Han, Mingwei Wei, Xiuyu Zheng, et al.
Expert Review of Vaccines|February 4, 2026
A self-controlled case series study on the safety of a live attenuated herpes zoster vaccine in ChinaXiang Cao, Mingwei Wei, Xiang Huo, et al.
The Journal of Infectious Diseases|January 13, 2017
2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label StudyMingwei Wei, Fanyue Meng, Shiyuan Wang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 17, 2025
Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trialShenyu Wang, Pengfei Jin, Yaru Quan, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Cancer|November 8, 2024
Immunofluorescence-Verified Sphingolipid Signatures Indicate Improved Prognosis in Liver Cancer PatientsLujuan Pan, Huijuan Huang, Pengpeng Zhang, et al.
Vaccines|April 27, 2026
Safety and Immunogenicity of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase III, Randomized, Blinded, Positive-Control Clinical Trial in Infants Aged Two MonthsHao Zhang, Yanjun Chen, Bidan Xu, et al.
BMJ Open|October 5, 2023
Single-arm, phase II study of intra-arterial chemotherapy plus total neoadjuvant therapy to optimise complete response in distal rectal cancer: a study protocolWenpeng Huang, Puda Huang, Houji Guo, et al.
Infectious Diseases and Therapy|July 6, 2026
Safety Profiles of Seasonal Influenza Vaccines in Chinese Children and Adolescents: A Pooled Analysis of Five Clinical StudiesLe Hu, Yue Liu, Siyue Jia, et al.
Frontiers in Immunology|September 5, 2024
A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in ChinaXu Han, Hongxing Pan, Pengfei Jin, et al.
Human Vaccines & Immunotherapeutics|February 24, 2025
Immunogenicity and safety of 1 versus 2 doses of quadrivalent-inactivated influenza vaccine in children aged 3-8 years with or without previous influenza vaccination historiesFeng Wen, Sheng Liu, Li Zhou, et al.
Vaccines|June 27, 2024
Immunogenicity, Safety, and Immune Persistence of One Dose of SARS-CoV-2 Recombinant Adenovirus Type-5 Vectored Vaccine in Children and Adolescents Aged 6-17 Years: An Immunobridging TrialXu Han, Mingwei Wei, Xiuyu Zheng, et al.
Expert Review of Vaccines|February 4, 2026
A self-controlled case series study on the safety of a live attenuated herpes zoster vaccine in ChinaXiang Cao, Mingwei Wei, Xiang Huo, et al.
The Journal of Infectious Diseases|January 13, 2017
2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label StudyMingwei Wei, Fanyue Meng, Shiyuan Wang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 17, 2025
Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trialShenyu Wang, Pengfei Jin, Yaru Quan, et al.
Pageof 4